No Detail Found!

Neutrophil to lymphocyte ratio vs platelets to lymphocyte ratio: biomarkers to predict severity of disease and their comparison in patients of COVID-19

Author(s)
Muhammad Adil Combined Military Hospital Thal/National University of Medical Sciences (NUMS), Pakistan
Zahid Farooq Baig Combined Military Hospital Lahore/National University of Medical Sciences (NUMS), Pakistan
Muhammad Amir Combined Military Hospital Peshawar/National University of Medical Sciences (NUMS) Pakistan
Sohail Saqib Chatha Combined Military Hospital Thal/National University of Medical Sciences (NUMS), Pakistan
Aamir Habib Combined Military Hospital Bannu/National University of Medical Sciences (NUMS) Pakistan
Muhammad Majid Combined Military Hospital Kohat/National University of Medical Sciences (NUMS) Pakistan
Abstract
Objective: To determine and compare Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) in predicting severity of disease in patients with COVID-19. Study Design: Cross sectional comparative study. Place and Duration of Study: Department of Medicine, Combined Military Hospital, Thal, from Apr to Jul 2020. Methodology: Sixty One patients of COVID-19 confirmed through polymerase chain reaction were recruited and divided into severe and non severe disease. Complete blood counts were done. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio were calculated and analyzed. Results: Fourteen patients (23%) of severe disease had mean age of 49.93 ± 19.42 and 47 patients (77%) with nonsevere disease had mean age of 33.32 ± 9.16. The mean Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte ratio in patients who had severe disease was 7.20 ± 4.20 and 204.25 ± 148.42 (p=0.001 and p=0.026) respectively. The diagnostic performance of both Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio produced statistically significant area under the curve (AUC), (p<0.001). The adjusted and unadjusted area under curve for Neutrophil to Lymphocyte Ratio was 0.92 (95% CI: 0.85-1.00) and 0.923 (95% CI: 0.839-1.000) and for Platelet to Lymphocyte Ratio it was 0.883 (95% CI: 0.781-0.985) and 0.825(95% CI: 0.707-0.943) respectively. Conclusion: Elevated Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are independent biomarkers which predict severity of disease in COVID-19 patients with Neutrophil to Lymphocyte Ratio being better predictor in terms of diagnostic accuracy.
Publication Details
Page(s) 1609-1615
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 70, Issue: 6, Year: 2020

Request the full text from PASTIC

Keywords
Platelet to Lymphocyte ratio., Corona Virus Disease 2019 (COVID-19), Neutrophil to Lymphocyte Ratio
0

Citations

0

Downloads

86

Views